Urologix, Inc.
ULGX
$0.0001
$0.000.00%
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -349.00K | -357.00K | -437.00K | -3.53M | -1.66M |
| Total Depreciation and Amortization | 111.00K | 116.00K | 134.00K | 140.00K | 145.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 144.00K | 151.00K | 167.00K | 3.17M | 872.00K |
| Change in Net Operating Assets | 60.00K | 122.00K | -34.00K | 126.00K | 198.00K |
| Cash from Operations | -34.00K | 32.00K | -170.00K | -91.00K | -449.00K |
| Capital Expenditure | -7.00K | 0.00 | -1.00K | -4.00K | -1.00K |
| Sale of Property, Plant, and Equipment | 4.00K | 5.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00K | -52.00K | -2.00K | -3.00K | -1.00K |
| Cash from Investing | -4.00K | -47.00K | -3.00K | -7.00K | -2.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -38.00K | -15.00K | -173.00K | -98.00K | -451.00K |
